Little Rock, ARKANSAS3 Active Studies

Advanced Solid Tumors Clinical Trials in Little Rock, ARKANSAS

Find 3 actively recruiting advanced solid tumors clinical trials in Little Rock, ARKANSAS. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
1,038
Enrolling

Recruiting Advanced Solid Tumors Studies in Little Rock

About Advanced Solid Tumors Clinical Trials in Little Rock

Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.

There are currently 3 advanced solid tumors clinical trials recruiting participants in Little Rock, ARKANSAS. These studies are seeking a combined 1,038 participants. Research is being sponsored by Artios Pharma Ltd, Eisai Inc., Novita Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Advanced Solid Tumors Clinical Trials in Little Rock — FAQ

Are there advanced solid tumors clinical trials in Little Rock?

Yes, there are 3 advanced solid tumors clinical trials currently recruiting in Little Rock, ARKANSAS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Little Rock?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Little Rock research site will contact you about next steps.

Are clinical trials in Little Rock free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Little Rock studies also compensate for your time and travel.

What advanced solid tumors treatments are being tested?

The 3 active trials in Little Rock are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.

Data updated March 2, 2026 from ClinicalTrials.gov